 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, November 29, 2006, 26(48):12427-12438; doi:10.1523/JNEUROSCI.4052-06.2006
Previous Article | Next Article
Cellular/Molecular
p38 Mitogen-Activated Protein Kinase Contributes to Adenosine A1 Receptor-Mediated Synaptic Depression in Area CA1 of the Rat Hippocampus
Tyson B. Brust, Francisco S. Cayabyab, Ning Zhou, andBrian A. MacVicar Brain Research Centre, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada V6T 2B5
Correspondence should be addressed to Dr. Brian A. MacVicar, Brain Research Centre, Department of Psychiatry, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5. Email: bmacvica{at}interchange.ubc.ca
Adenosine is arguably the most potent and widespread presynaptic modulator in the CNS, yet adenosine receptor signal transduction pathways remain unresolved. Here, we demonstrate a novel mechanism in which adenosine A1 receptor stimulation leads to p38 mitogen-activated protein kinase (MAPK) activation and contributes to the inhibition of synaptic transmission. Western blot analysis indicated that selective A1 receptor activation [with N6-cyclopentyladenosine (CPA)] resulted in rapid increases in phosphorylated p38 (phospho-p38) MAPK immunoreactivity in membrane fractions, and decreases in phospho-p38 MAPK in cytosolic fractions. Immunoprecipitation with a phospho-p38 MAPK antibody revealed constitutive association of this phosphoprotein with adenosine A1 receptors. Phospho-p38 MAPK activation by A1 receptor stimulation induced translocation of PP2a (protein phosphatase 2a) to the membrane. We then examined the actions of p38 MAPK activation in A1 receptor-mediated synaptic inhibition. Excitatory postsynaptic field potentials evoked in area CA1 of the rat hippocampus markedly decreased in response to adenosine (10 µM), the A1 receptor agonist CPA (40 nM), or a 5 min exposure to hypoxia. These inhibitory responses were mediated by A1 receptor activation because the selective antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine) (100 nM) prevented them. In agreement with the biochemical analysis, the selective p38 MAPK inhibitor SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole] (25 µM) blocked the inhibitory actions of A1 receptor activation, whereas both the inactive analog SB202474 [4-ethyl-2-(p-methoxyphenyl)-5-(4'-pyridyl)-1H-imidazole] (25 µM) and the ERK 1/2 (extracellular signal-regulated kinase 1/2) MAPK inhibitor PD98059 [2'-amino-3'-methoxyflavone] (50 µM) were ineffective. In contrast, the p38 MAPK inhibitors did not inhibit GABAB-mediated synaptic depression. These data suggest A1 receptor-mediated p38 MAPK activation is a crucial step underlying the presynaptic inhibitory effect of adenosine on CA3–CA1 synaptic transmission.
Key words: adenosine; A1 receptor; hippocampus; p38 mitogen-activated protein kinase; hypoxia; synaptic depression; presynaptic inhibition; field EPSP
Received Jan. 8, 2006; revised Oct. 20, 2006; accepted Oct. 25, 2006.
Correspondence should be addressed to Dr. Brian A. MacVicar, Brain Research Centre, Department of Psychiatry, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5. Email: bmacvica{at}interchange.ubc.ca
This article has been cited by other articles:
Y. Izumi and C. F. Zorumski
Direct Cortical Inputs Erase Long-Term Potentiation at Schaffer Collateral Synapses
J. Neurosci., September 17, 2008; 28(38): 9557 - 9563.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|